ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

A Successful Kidney Transplantation from Hepatitis C NAT Positive Deceased Donor to an HIV Positive Recipient with Previous History of Treated HCV Infection

R. H. Naik, S. Shawar, H. Schaefer

Vanderbilt University Medical Center, Nashville, TN

Meeting: 2020 American Transplant Congress

Abstract number: A-048

Keywords: Hepatitis C, High-risk, HIV virus, Kidney transplantation

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: Kidney Deceased Donor Selection

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • HIV, HBV, and HCV Screening with NAT and Serology in the OPO Setting
  • Hepatitis C Antibody Positive (HCV Ab+)/Nucleic Acid Test Negative (NAT -) Deceased Donor Kidney Transplantation into Hepatitis C Negative (HCV -) Recipients: Is It Safe?

*Purpose: Due to a shortage of deceased donor kidney organs, increased waiting times have been associated with adverse outcomes post kidney transplantation. The recent breakthrough of HCV treatment with direct-acting antivirals has changed transplant practice worldwide by allowing the use of HCV+ deceased donor organs into HCV- recipients. Here we describe a case of successful kidney transplant with an HCV NAT+ deceased donor into an HIV positive recipient with the previous history of treated hepatitis C.

*Methods: Case Summary: The patient is a 54 year of African American male with a history of ESRD secondary to biopsy-proven HIV nephropathy. He has been on hemodialysis for 8 years and his HIV has been successfully treated with undetectable viral load and CD4 counts >200 consistently. He has a history of hepatitis C (genotype 1A) treated with glecaprevir/pibrentasvir x 12 weeks with negative RNA in 2018. He underwent deceased donor kidney transplantation from an HCV NAT+ donor (genotype 2) in March 2019. He received basiliximab and methylprednisone induction immunosuppression followed by tacrolimus, mycophenolate mofetil, and prednisone for maintenance. He had immediate graft function with nadir serum creatinine to 1.4 mg/dl followed by stable kidney function over the 8 months of follow up. His HCV RNA quantitative 12 days after transplant was 338,370 IU/ml. He was treated with elbasvir and grazoprevir x 12 weeks starting 6 weeks after transplantation with sustained viral response. His HIV viral load remains undetectable on current antiretroviral therapy.

*Results: .

*Conclusions: To our knowledge, this is one of the first reported cases of using an HCV NAT+ deceased donor kidney into an HIV+ recipient. Recently conducted pilot studies show that the use of HCV NAT+ donor kidneys in uninfected recipients is a potential avenue to increase rates of kidney transplantation without significant adverse outcomes in the early postoperative period. In addition, HCV- recipients who acquire HCV can be successfully treated. Our case is also unique in that the recipient was successfully treated for the HCV genotype 1A before transplant and later infected with HCV genotype 2 from the donor kidney and successfully treated post-transplant while maintaining excellent allograft function.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Naik RH, Shawar S, Schaefer H. A Successful Kidney Transplantation from Hepatitis C NAT Positive Deceased Donor to an HIV Positive Recipient with Previous History of Treated HCV Infection [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/a-successful-kidney-transplantation-from-hepatitis-c-nat-positive-deceased-donor-to-an-hiv-positive-recipient-with-previous-history-of-treated-hcv-infection/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.